Victory Capital Management Inc. Reduces Stock Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Victory Capital Management Inc. reduced its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 6.2% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,765 shares of the company’s stock after selling 2,614 shares during the period. Victory Capital Management Inc. owned approximately 0.26% of U.S. Physical Therapy worth $3,675,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Innealta Capital LLC purchased a new position in shares of U.S. Physical Therapy in the 2nd quarter worth $30,000. Northwest Bank & Trust Co purchased a new position in shares of U.S. Physical Therapy in the 4th quarter worth $37,000. Ridgewood Investments LLC bought a new stake in shares of U.S. Physical Therapy in the 2nd quarter worth about $51,000. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of U.S. Physical Therapy by 268.5% in the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 549 shares of the company’s stock worth $61,000 after acquiring an additional 400 shares during the last quarter. Finally, Principal Securities Inc. bought a new stake in shares of U.S. Physical Therapy in the 4th quarter worth about $100,000.

U.S. Physical Therapy Trading Down 0.7 %

Shares of USPH opened at $83.97 on Tuesday. U.S. Physical Therapy, Inc. has a 1-year low of $78.08 and a 1-year high of $113.63. The company has a 50-day moving average of $89.41 and a 200 day moving average of $97.72. The firm has a market capitalization of $1.27 billion, a price-to-earnings ratio of 68.19, a PEG ratio of 4.06 and a beta of 1.39. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.88 and a quick ratio of 1.88.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The company had revenue of $167.19 million for the quarter, compared to the consensus estimate of $163.34 million. During the same quarter in the previous year, the business earned $0.76 EPS. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. On average, research analysts expect that U.S. Physical Therapy, Inc. will post 2.51 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Investors of record on Friday, August 23rd were issued a dividend of $0.44 per share. The ex-dividend date was Friday, August 23rd. This represents a $1.76 dividend on an annualized basis and a yield of 2.10%. U.S. Physical Therapy’s payout ratio is 143.09%.

Insider Activity at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the sale, the chief operating officer now owns 7,038 shares in the company, valued at approximately $580,635. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other U.S. Physical Therapy news, Director Kathleen A. Gilmartin purchased 2,000 shares of U.S. Physical Therapy stock in a transaction dated Tuesday, September 3rd. The stock was acquired at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the acquisition, the director now owns 18,904 shares in the company, valued at approximately $1,627,445.36. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the sale, the chief operating officer now owns 7,038 shares of the company’s stock, valued at approximately $580,635. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. Barrington Research lowered their target price on shares of U.S. Physical Therapy from $122.00 to $108.00 and set an “outperform” rating for the company in a report on Thursday, August 15th. One equities research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $112.50.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.